Here is the synopsis of our sample research paper on Controlling Prescription Drug Costs. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 16 page paper looks at the different issues surrounding the pressures to control drug prices on persecution drugs. The paper outlines the various influences, such as political, economic, social and moral. The paper then uses a case study of Medicaid to show how states have attempted to cut costs. The paper focuses on Oregon. The bibliography cites 9 sources.
Page Count:
16 pages (~225 words per page)
File: TS14_TEdrugcost.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
healthcare programme, provided though a state scheme such as Medicaid or pod for privately. The issue is the way that the resources are used. Prescriptions make up a large percentage
of all medical costs, and the correct use of prescriptions drugs and treatments may result in lower downstream healthcare costs. However there are also pressures to reduce the level of
spending in an area where there is the need or desire to reduce costs. Medical care has many demands. The way demands are made may also be complex, as
there is an opportunity cost to ay treatment, for many drugs that are optional, or required due to self inflicted conditions or those which do not create harm
The need to cut costs places pressure on other areas of the health services as well. However, , cutting cists is also difficult a despite
the pressure to cut costs there are also demands placed on the health services to increase care provisions, to increase standards and to make use of the new knowledge that
emerges regularly, with new methods of diagnosis and treatment. When new treatments become available they are initially very expensive. Drug companies undertake
lengthy and costly tests to create the drug. Once it is able to be prescribed the initial cost will be high in order to recoup the costs incurred. Drug companies
also wish to make a profit, and as such a profit margin is also built into the drug that will also allow for the volatility of the market and the
time lag between developing new drugs and the limited period of patent protection given under different countries laws. It is only as
...